retatrutide triple agonist weight loss trial First phase 3 data, a Triumph of Science! Retatrutide, an investigational triple hormone
Description
Thats what well get into now
Dawes, P., L
PubMed, Xing, Changyang, et al
Monami M, Marchionni N, Mannucci E (2009) Glucagon-like peptide-1 receptor agonists in type 2 diabetes: a meta-analysis of randomized clinical trials
Retatrutide does not belong to a scientific category called GLP-3
The company states that these clinicians retain sole decision-making authority over whether to prescribe compounded GLP-1 medications
